Completed PHASE1 INTERVENTIONAL 3-arm NCT02163707

UW Psilocybin Pharmacokinetics Study

Pharmacokinetics of Psilocybin in Normal Adult Volunteers

Sponsor: University of Wisconsin, Madison

Conditions Healthy

Interventions Psilocybin

Updated 7 times since 2017 Last updated: Apr 13, 2020 Started: Jun 30, 2014 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02163707, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by University of Wisconsin, Madison, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
May 2020 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — May 2020 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Wisconsin, Madison

Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madison, United States